eXoZymes Inc. Common Stock EXOZ Income Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| —— | —— | ||
| $3.71M+98.4% | $1.87M— | ||
| $6.01M+47.9% | $4.06M— | ||
| $9.72M+63.8% | $5.93M— | ||
| -$9.72M-63.8% | -$5.93M— | ||
| $362.09K+367% | $77.61K— | ||
| —— | -$6.83K— | ||
| -$9.26M-58.1% | -$5.86M— | ||
| -$105.21K— | —— | ||
| -$9.16M-56.3% | -$5.86M-188% | ||
| -$1.08-20.0% | -$0.90— | ||
| -$9.43M-66.4% | -$5.66M— | ||
| -$9.72M-63.8% | -$5.93M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is eXoZymes Inc. Common Stock's revenue?
- eXoZymes Inc. Common Stock (EXOZ) generated $70.1K in revenue over the trailing twelve months.
- Is eXoZymes Inc. Common Stock profitable?
- eXoZymes Inc. Common Stock is not currently profitable: it reported a net loss of $9.7M over the trailing twelve months, a -2909.1% net margin.
- What is eXoZymes Inc. Common Stock's earnings per share?
- eXoZymes Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.14.
- Where does eXoZymes Inc. Common Stock's income statement data come from?
- Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
